BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16325002)

  • 1. Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors Increased yield of dopamine cells is dependent on embryonic donor age.
    Torres EM; Monville C; Lowenstein PR; Castro MG; Dunnett SB
    Brain Res Bull; 2005 Dec; 68(1-2):31-41. PubMed ID: 16325002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
    Espejo M; Cutillas B; Arenas TE; Ambrosio S
    Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells.
    Apostolides C; Sanford E; Hong M; Mendez I
    Neuroscience; 1998 Mar; 83(2):363-72. PubMed ID: 9460746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compacted DNA nanoparticle gene transfer of GDNF to the rat striatum enhances the survival of grafted fetal dopamine neurons.
    Yurek DM; Flectcher AM; Kowalczyk TH; Padegimas L; Cooper MJ
    Cell Transplant; 2009; 18(10):1183-96. PubMed ID: 19650971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor.
    Krobert K; Lopez-Colberg I; Cunningham LA
    Exp Neurol; 1997 Jun; 145(2 Pt 1):511-23. PubMed ID: 9217087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
    Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
    Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
    Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of functional deficits following early donor age ventral mesencephalic grafts in a rat model of Parkinson's disease.
    Torres EM; Dowd E; Dunnett SB
    Neuroscience; 2008 Jun; 154(2):631-40. PubMed ID: 18468807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival of young donor age dopamine grafts in a rat model of Parkinson's disease.
    Torres EM; Monville C; Gates MA; Bagga V; Dunnett SB
    Neuroscience; 2007 Jun; 146(4):1606-17. PubMed ID: 17478050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsulation of young donor age dopaminergic grafts in a GDNF-loaded collagen hydrogel further increases their survival, reinnervation, and functional efficacy after intrastriatal transplantation in hemi-Parkinsonian rats.
    Moriarty N; Cabré S; Alamilla V; Pandit A; Dowd E
    Eur J Neurosci; 2019 Feb; 49(4):487-496. PubMed ID: 30054941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine cells in nigral grafts differentiate prior to implantation.
    Sinclair SR; Fawcett JW; Dunnett SB
    Eur J Neurosci; 1999 Dec; 11(12):4341-8. PubMed ID: 10594660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
    Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
    Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologically controlled, discontinuous GDNF gene therapy restores motor function in a rat model of Parkinson's disease.
    Tereshchenko J; Maddalena A; Bähr M; Kügler S
    Neurobiol Dis; 2014 May; 65():35-42. PubMed ID: 24440408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum by a subset of aldehyde dehydrogenase-positive TH neurons.
    Haque NS; LeBlanc CJ; Isacson O
    Cell Transplant; 1997; 6(3):239-48. PubMed ID: 9171157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
    Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
    Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-grafts of fetal ventral mesencephalon and fibroblasts expressing sonic hedgehog: effect on survival and function of dopamine grafts.
    Yurek DM; Fletcher-Turner A; Moore J; Chai L; Mahanthappa N
    Cell Transplant; 2001; 10(8):665-71. PubMed ID: 11814108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fetal mesencephalic grafts, AAV-delivered GDNF, and both combined in an MPTP-induced nonhuman primate Parkinson's model.
    Redmond DE; McEntire CR; Kingsbery JP; Leranth C; Elsworth JD; Bjugstad KB; Roth RH; Samulski RJ; Sladek JR
    Mol Ther; 2013 Dec; 21(12):2160-8. PubMed ID: 23913185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
    Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
    Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease.
    Lapchak PA; Araujo DM; Hilt DC; Sheng J; Jiao S
    Brain Res; 1997 Nov; 777(1-2):153-60. PubMed ID: 9449424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.